View 10x Genomics, Inc. (TXG) current and estimated P/E ratio data provided by Seeking Alpha.
NASDAQ TXG opened at $15.08 on Friday. The company has a market capitalization of $1.83 billion, a P/E ratio of -9.86 and a beta of 1.83. 10x Genomics has a 52-week low of $12.95 and a 52-week ...
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
Earlier today the fact that Samsung is working on the Galaxy XCover7 Pro rugged smartphone leaked, and now the same source is back with some more information about three upcoming Samsung tablets ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Leerink Partners analyst Puneet Souda has maintained their bullish stance on TXG stock, giving a Buy rating on January 13. Discover outperforming stocks and invest smarter with Top Smart Score ...
Has Mizuno got a deal for you. Many golfers think of Mizuno primarily, if not entirely, as an iron company. I could write 4,000 words about the company’s iconic player’s iron designs. I could write a ...
With lightweight speed at the forefront of the design, Mizuno release the Alpha II Teaser Edition, introducing us to a new era of fast in football. The boot arrives in a bold colourway, teasing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results